TY  - RPRT
TI  - Exploring novel fluorine rich fuberidazole derivatives as hypoxic cancer inhibitors: design, synthesis, pharmacokinetics, molecular docking and DFT evaluations
AU  - Taj, M. B.
AU  - Ali, O. M.
PY  - 2022
DO  - 10.1101/2022.01.06.475235
UR  - https://www.biorxiv.org/content/10.1101/2022.01.06.475235v1
ID  - 10.1101/2022.01.06.475235
ER  -